Mangoceuticals, Inc. (MGRX) Q1 2026 Annual Earnings
MGRX·Reported May 19, 2026·Before market open
Mangoceuticals, Inc. reported Q1 2026 revenue of $67.9K (-37.9% YoY). Diluted EPS came in at $-0.22 (+82.9% YoY).
Revenue
$67.9K
Diluted EPS
$-0.22
Financial Snapshot
Trailing eight quarters through Q1 2026
Q1 2026 Earnings FAQ
Common questions about Mangoceuticals, Inc.'s Q1 2026 earnings report.
Mangoceuticals, Inc. (MGRX) reported Q1 2026 earnings on May 19, 2026 before market open.
Mangoceuticals, Inc. reported revenue of $67.9K and diluted EPS of $-0.22 for Q1 2026.
Compared to the same quarter a year prior, revenue declined 37.9% from $109.3K a year earlier and diluted EPS grew 82.9% from $-1.29.
You can read the 10-K periodic report (0001493152-26-014478) directly on SEC EDGAR. The filing index links above go to sec.gov.